Healthcare -
Biotechnology - NASDAQ - US
$ 0.1771
-5.09 %
$ 1.88 M
Market Cap
-0.04
P/E
HEPA - COST OF REVENUE
Cost of Revenue HEPA - Hepion Pharmaceuticals, Inc.
67.1 K
LAST VALUE
-11.69%
2 YEAR CAGR
29.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR